BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33842389)

  • 1. Epigallocathechin-
    Inacio JDF; Fonseca MS; Limaverde-Sousa G; Tomas AM; Castro H; Almeida-Amaral EE
    Front Cell Infect Microbiol; 2021; 11():640561. PubMed ID: 33842389
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
    Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
    Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
    Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
    Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
    Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico and in vitro comparative activity of green tea components against Leishmania infantum.
    Khademvatan S; Eskandari K; Hazrati-Tappeh K; Rahim F; Foroutan M; Yousefi E; Asadi N
    J Glob Antimicrob Resist; 2019 Sep; 18():187-194. PubMed ID: 30797085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
    Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
    Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of antimony treatment in leishmaniasis.
    Baiocco P; Colotti G; Franceschini S; Ilari A
    J Med Chem; 2009 Apr; 52(8):2603-12. PubMed ID: 19317451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action.
    Inacio JD; Gervazoni L; Canto-Cavalheiro MM; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3093. PubMed ID: 25144225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis.
    Inacio JD; Canto-Cavalheiro MM; Menna-Barreto RF; Almeida-Amaral EE
    Exp Parasitol; 2012 Oct; 132(2):151-5. PubMed ID: 22735546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.
    de Lucio H; Revuelto A; Carriles AA; de Castro S; García-González S; García-Soriano JC; Alcón-Calderón M; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 244():114878. PubMed ID: 36332553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.
    Vishwakarma P; Parmar N; Chandrakar P; Sharma T; Kathuria M; Agnihotri PK; Siddiqi MI; Mitra K; Kar S
    Cell Mol Life Sci; 2018 Feb; 75(3):563-588. PubMed ID: 28900667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel indol-3-yl-thiosemicarbazone derivatives: Obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies.
    da Silva PR; de Oliveira JF; da Silva AL; Queiroz CM; Feitosa APS; Duarte DMFA; da Silva AC; de Castro MCAB; Pereira VRA; da Silva RMF; Alves LC; Dos Santos FAB; de Lima MDCA
    Chem Biol Interact; 2020 Jan; 315():108899. PubMed ID: 31738906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
    Venkatesan SK; Shukla AK; Dubey VK
    J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione and the redox control system trypanothione/trypanothione reductase are involved in the protection of Leishmania spp. against nitrosothiol-induced cytotoxicity.
    Romão PR; Tovar J; Fonseca SG; Moraes RH; Cruz AK; Hothersall JS; Noronha-Dutra AA; Ferreira SH; Cunha FQ
    Braz J Med Biol Res; 2006 Mar; 39(3):355-63. PubMed ID: 16501815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of
    Madia VN; Ialongo D; Patacchini E; Exertier C; Antonelli L; Colotti G; Messore A; Tudino V; Saccoliti F; Scipione L; Ilari A; Costi R; Di Santo R
    Molecules; 2023 Jan; 28(1):. PubMed ID: 36615531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical and folding parameters of trypanothione reductase from Leishmania infantum.
    Shukla AK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2011 Sep; 165(1):13-23. PubMed ID: 21445596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of L. infantum trypanothione synthetase inhibitors with leishmanicidal activity from a (non-biased) in-house chemical library.
    Alcón-Calderón M; de Lucio H; García-Soriano JC; Revuelto A; de Castro S; López-Gutiérrez C; San-Félix A; Quesada E; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 243():114675. PubMed ID: 36075146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.